Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.12% |
| 2 | Technology | 12.96% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11.23% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Goldman Sachs
GS
$304B
| – | – |
-49,200
| Closed | -$7.93M |
|
3327
Gray Television
GTN
$518M
| – | – |
-78,150
| Closed | -$810K |
|
3328
HCA Healthcare
HCA
$89.3B
| – | – |
-45,100
| Closed | -$3.41M |
|
3329
Howard Hughes
HHH
$4.05B
| – | – |
-20,665
| Closed | -$2.26M |
|
3330
Hartford Financial Services
HIG
$37.8B
| – | – |
-345,300
| Closed | -$14.8M |
|
|
HIMX
3331
Himax Technologies
HIMX
$2.56B
| – | – |
-347,361
| Closed | -$2.98M |
|
3332
HP
HPQ
$28.4B
| – | – |
-94,700
| Closed | -$1.47M |
|
3333
HSBC
HSBC
$357B
| – | – |
-9,409
| Closed | -$320K |
|
3334
Huntsman Corp
HUN
$1.82B
| – | – |
-1,301,100
| Closed | -$21.2M |
|
|
AGIG
3335
Abundia Global Impact Group
AGIG
$38.9M
| – | – |
-102
| Closed | -$2K |
|
3336
Hexcel
HXL
$7.72B
| – | – |
-300,500
| Closed | -$13.3M |
|
3337
Integra LifeSciences
IART
$1.41B
| – | – |
-38,060
| Closed | -$1.57M |
|
3338
Interactive Brokers
IBKR
$41.5B
| – | – |
-454,400
| Closed | -$4.01M |
|
3339
ICICI Bank
IBN
$106B
| – | – |
-3,261,720
| Closed | -$22.1M |
|
3340
Icahn Enterprises
IEP
$5.34B
| – | – |
-9,386
| Closed | -$474K |
|
3341
Incyte
INCY
$24.4B
| – | – |
-62,900
| Closed | -$5.93M |
|
3342
ING
ING
$102B
| – | – |
-945,210
| Closed | -$11.7M |
|
3343
Iovance Biotherapeutics
IOVA
$2.92B
| – | – |
-19,000
| Closed | -$156K |
|
3344
IQVIA
IQV
$39.8B
| – | – |
-242,300
| Closed | -$19.6M |
|
|
IRBT
3345
DELISTED
iRobot
IRBT
| – | – |
-68,460
| Closed | -$3.01M |
|
3346
Iridium Communications
IRDM
$5.28B
| – | – |
-156,600
| Closed | -$1.27M |
|
3347
Integer Holdings
ITGR
$4.25B
| – | – |
-24,900
| Closed | -$540K |
|
3348
ITT
ITT
$19.3B
| – | – |
-198,600
| Closed | -$7.12M |
|
|
KALV
3349
DELISTED
KalVista Pharmaceuticals
KALV
| – | – |
-17,337
| Closed | -$112K |
|
3350
KeyCorp
KEY
$24.6B
| – | – |
-3,964,923
| Closed | -$48.3M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.